Pay in 4 interest-free payments of $7.27 Learn more
Ships within 48 hours · Estimated delivery Oct 25 - Oct 30
Also called Bremelanotide, PT-141 is a synthetic hormone approved by the FDA to treat acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women
Try to take it at the same time each day to build consistency and effectiveness
In two phase 3 clinical trials involving more than 1,200 premenopausal women, PT-141 (bremelanotide) was shown to significantly improve sexual desire and reduce distress related to low desire compared with placebo ( Kingsberg et al., 2019, Obstetrics & Gynecology )
Key active ingredients include Sodium Bicarbonate and Hyaluronic Acid (High Molecular Weight)
Legal compounding pharmacies cannot compound BPC-157 at this time
US$ 22.39
US$ 21.62
US$ 28.98
US$ 29.23
US$ 29.20
US$ 23.51
US$ 29.81
